Active Surveillance of Prostate Cancer: Effective Disease Management Strategy

Active surveillance of prostate cancer in low-risk patients is an effective disease management protocol. The Canary PASS study results demonstrate favorable health outcomes among participants over nearly a decade of follow-up. The study, published in JAMA on May 30, led by researchers from the Fred Hutch Cancer Center, highlights the importance of regular PSA exams and prostate biopsies in monitoring cancer growth. This structured protocol aims to avoid unnecessary treatment and reduce overtreatment of slow-growing prostate tumors. Lisa Newcomb, PhD, Deputy Director of Canary PASS, notes that active surveillance is a safe and efficient strategy for favorable risk prostate cancer.